You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Cost recovery implementation statement: Prescription medicines, From 1 July 2015
Version 1.0, July 2015
This CRIS provides information on how the Therapeutic Goods Administration (TGA) implements cost recovery associated with the registration of prescription medicines onto the Australian Register of Therapeutic Goods (ARTG) and the ongoing monitoring and surveillance of prescription medicines registered on the ARTG. It also reports financial and non-financial performance information for prescription medicines regulation and contains financial forecasts for 2015-16. The TGA will maintain the CRIS until the activity or cost recovery for the activity has been discontinued.